Skip to main content

Animal Models of Alzheimer’s Disease and Other Dementias: Past, Present, and Future

58kviews
Editorial06 January 2025
Editorial: Animal models of Alzheimer's disease and other dementias: past, present, and future
Ines Moreno-Gonzalez, Jesus Garcia-Martin and Roberta Marongiu

Neurodegenerative diseases, particularly Alzheimer's disease and related dementias (AD/ADRD), represent a significant global health challenge. As of 2019, dementia affected over 57 million individuals worldwide, with projections suggesting this number could exceed 150 million by 2050 (GBD 2019Dementia Forecasting Collaborators, 2022). This growing prevalence underscores the need for effective treatments and a deeper understanding of these diseases. Animal models are essential for elucidating the pathology of ADRD, offering valuable insights into disease mechanisms and enabling the evaluation of therapeutic strategies under controlled conditions. Specifically, transgenic models that overexpress human genes linked to familial AD have been instrumental for replicating hallmark features of AD, including the formation of extracellular amyloid-β plaques and intracellular tau neurofibrillary tangles, closely mirroring human neuropathology (Sanchez-Varo, 2022) neuroinflammatory processes associated with cerebrovascular dementia. In their study, accelerated ovarian failure was pharmacologically induced in transgenic SWDI mice, which express a human amyloid-β precursor protein with vasculotropic mutations (Davis et al., 2004). Their findings revealed dysfunction in key components of the neurovascular unit within hippocampal regions at early stages of pathology, suggesting that the perimenopausal period may represent a particularly vulnerable window for the development of dementia.As models evolve to better capture the complex risk factors associated with dementia, human stem cell transplantation models offer a promising alternative to address the longstanding challenge of limited translatability from animal studies to clinical applications. In this issue, Ifediora et al. introduce human induced pluripotent stem cell (iPSC) transplantation models as a significant advancement in AD research. By transplanting iPSC-derived neurons, astrocytes, and microglia into animal brains, these models enable the study of human cell interactions within a living brain environment, offering a closer approximation of human disease conditions than traditional isolated cell cultures. This innovative approach, as described by the authors, holds promise for preclinical studies focused on testing and optimizing therapeutic strategies. However, challenges such as replicating long-term aging processes and ensuring stable cell integration remain in these chimeric transplantation systems. Future models emphasizing prolonged observation periods and enhanced cell integration may better capture the chronic and progressive nature of AD and related dementias.Recent Through these models, the authors delve into the mechanisms linking elevated blood pressure to neurodegeneration. While pathogenic pathways vary among these models, the authors highlight several shared, key processes underlying hypertension-induced brain damage, demonstrating the versatility of animal models presented in this mini review.Beyond hypertension, sleep disturbances are also gaining recognition as a significant risk factor for dementia (Shi et al., 2018). The rising global impact of neurodegenerative diseases, especially AD, highlights the urgent need to develop improved treatments and deepen our understanding of disease neuropathophysiology. Traditional animal models have been invaluable for studying dementia.InNew and refined animal models that incorporate genetic and environmental risk factorsalong with human stem cell and advanced computational approaches -are bridging the gap between animal and human studies. This integrated approach presents a promising future where advanced tools converge offering new opportunities to develop precise and effective interventions for dementia and address this critical public health challenge.

IM-G, JG-M and RM have contributed to manuscript writing and editing. All authors have made a substantial intellectual contribution to this manuscript and approved it for publication.

3,587 views

4 citations

Modeling sporadic Alzheimer’s disease in mice by combining Apolipoprotein E4 risk gene with environmental risk factors
ORIGINAL RESEARCH
27 February 2024
Modeling sporadic Alzheimer’s disease in mice by combining Apolipoprotein E4 risk gene with environmental risk factors
Kiruthika Ganesan, 3 more and Bryce Vissel
Developing effective treatment for Alzheimer's disease (AD) remains a challenge. This can be partially attributed to the fact that the mouse models used in preclinical research largely replicate familial form of AD, while majority of human cases are sporadic; both forms differ widely in the onset and origin of pathology, therefore requiring specific/targeted treatments. In this study, we aimed to model sporadic AD in mice by combining two of the many risk factors that are strongly implicated in AD: ApoE4, a major genetic risk factor, together with an inflammatory stimuli. Accordingly, we subjected ApoE4 knock in (KI) mice, expressing humanized ApoE4, to low doses of Lipopolysaccharide (LPS) injections (i.p, weekly, for four months). We assessed these animals for behavioral impairments at 6 months of age using Open Field, Y-maze and Barnes Maze Test. LPS induced hypoactivity was observed in the Open Field and Y-maze test, whereas spatial learning and memory was intact. We then quantified differences in dendritic spine density, which is a strong correlate of AD. ApoE4KI mice showed a significant reduction in the number of spines after treatment with LPS, whereas there were no obvious differences in the total number of microglia and astrocytes. To conclude, in the current study the APoEe4 risk gene increases the vulnerability of hippocampal neurons to inflammation induced spine loss, laying a foundation for an early sporadic AD mouse model.

7,393 views

10 citations

An explainable machine learning based prediction model for Alzheimer's disease in China longitudinal aging study
ORIGINAL RESEARCH
3 November 2023
An explainable machine learning based prediction model for Alzheimer's disease in China longitudinal aging study
Ling Yue, 3 more and Shi-fu Xiao
Alzheimer's disease (AD) is the most common cause of dementia. Accurate prediction and diagnosis of AD and its prodromal stage, i.e., mild cognitive impairment (MCI), is essential for the possible delay and early treatment for the disease. In this paper, we adopt the data from the China Longitudinal Aging Study (CLAS), which was launched in 2011, and includes a joint effort of 15 institutions all over the country. 4,411 people who are at least 60 years old participated in the project, where 3,514 people completed the baseline survey. The survey collected data including demographic information, daily lifestyle, medical history, and routine physical examination. In particular, we employ ensemble learning and feature selection methods to develop an explainable prediction model for AD and MCI. Five feature selection methods and nine machine learning classifiers are applied for comparison to find the most dominant features on AD/MCI prediction.The resulting model achieves accuracy of 89.2%, sensitivity of 87.7%, and specificity of 90.7% for MCI prediction, and accuracy of 99.2%, sensitivity of 99.7%, and specificity of 98.7% for AD prediction. We further utilize the SHapley Additive exPlanations (SHAP) algorithm to visualize the specific contribution of each feature to AD/MCI prediction at both global and individual levels. Consequently, our model not only provides the prediction outcome, but also helps to understand the relationship between lifestyle/physical disease history and cognitive function, and enables clinicians to make appropriate recommendations for the elderly. Therefore, our approach provides a new perspective for the design of a computer-aided diagnosis system for AD and MCI, and has potential high clinical application value.1 Ling Yue and Wugang Chen contributed equally to this study.

6,266 views

27 citations

ORIGINAL RESEARCH
15 November 2023
Hippocampal glial inflammatory markers are differentially altered in a novel mouse model of perimenopausal cerebral amyloid angiopathy
Jimcy Platholi, 7 more and Michael J. Glass

5,256 views

11 citations